The current state of intestine transplantation: Indications, techniques, outcomes and challenges

American Journal of Transplantation

Volumn 14, Issue 9, 2014, Pages 1976-1984

  Sudan, D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Health services and outcomes research; intestinal (allograft) function dysfunction; intestinal (native) function dysfunction; intestinal failure injury; intestine multi visceral transplantation; liver transplantation hepatology

Indexed keywords

BIOLOGICAL MARKER;

ALLOTRANSPLANTATION; BLOODSTREAM INFECTION; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH, DEVELOPMENT AND AGING; HEALTH CARE ACCESS; HUMAN; INFECTIOUS COMPLICATION; INTESTINAL FAILURE; INTESTINE TRANSPLANTATION; ISOLATED ORGAN; KIDNEY DISEASE; MEDICAL CARE; MEDICAL PROCEDURES; NOMENCLATURE; NUTRITIONAL HEALTH; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEPSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TISSUE ENGINEERING; TREATMENT INDICATION; INTESTINE; NUTRITIONAL STATUS; TRANSPLANTATION; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; HUMANS; INTESTINES; NUTRITIONAL STATUS; QUALITY OF LIFE; SURVIVAL RATE; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 84906259983     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12812     Document Type: Review

References (68)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2011 annual data report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2012.
2. ITR. 2013 bi-annual report. In:, Grant D, eds. Intestinal Transplant Registry. Toronto, ON: Intestinal Transplant Association, 2014.
3. Messing B, Lemann M, Landais P, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 1995; 108: 1005-1010.
4. Wales P, de Silva N, Kim J, Lecce L, Sandhua A, Moore A., Neonatal short bowel syndrome. J. Pediatric Surg 2005; 40: 755-762.
5. Spencer AU, Neaga A, West B, et al. Pediatric short bowel syndrome: Redefining predictors of success. Ann Surg 2005; 242: 403-409.
6. Squires RH, Duggan C, Teitlelbaum DH, et al. Natural history of pediatric intestinal failure: Initial report from the Pediatric Intestinal Failure Consortium. J Pediatr 2012; 161: 723-728.e2.
7. Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: Implications for intestinal transplantation. Gut 2011; 60: 17-25.
8. Oliveria C, Nasr A, Brindle M, Wales PW., Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: A meta-analysis. Pediatrics 2012; 129: 318-329.
9. Ghannoum MA, Isham N, Jacobs MR., Antimicrobial activity of B-Lock against bacterial and Candida spp. causing catheter-related bloodstream infections. Antimicrob Agents Chemother 2011; 55: 4430-4431.
10. Modi BP, Langer M, Ching YA, et al. Improved survival in a multidisciplinary short bowel syndrome program. J Pediatr Surg 2008; 43: 20-24.
11. Sigalet D, Boctor D, Brindle M, Lam V, Robertson M., Elements of successful intestinal rehabilitation. J Pediatr Surg 2011; 46: 150-156.
12. Sudan D, DiBaise J, Torres C, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2005; 9: 165-177.
13. Kaufmann SS, Atkinson JB, Bianchi A, et al. Indications for pediatric intestinal transplantation: A position paper of the American Society of Transplantation. Pediatr Transplant 2001; 5: 80-87.
14. Department of Health and Human Services. Centers for Medicare and Medicaid Services. Program memorandum intermediaries/carriers. Intestinal and multi-visceral transplantation. AB-02-040. 2002.
15. Zamvar V, Lazonby G, Puntis JW., Recurrent life-threatening sepsis in intestinal failure: Transplantation or foster care ? Arch Dis Child 2013; 98: 556-557.
16. Fishbein TM, Matsumoto CS., Intestinal replacement therapy: Timing and indications for referral of patients to an intestinal rehabilitation and transplant program. Gastroenterology 2006; 130 (2 Suppl): S147-S151.
17. Mangus RS, Tector AJ, Kubal CA, Fridell JA, Vianna RM., Multivisceral transplantation: Expanding indications and improving outcomes. J Gastrointest Surg 2013; 17: 179-186; discussion 186-187.
18. Abu-Elmaqd KM., Intestinal transplantation for short bowel syndrome and gastrointestinal failure: Current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 2006; 130 (2 Suppl 1): S132-S137.
19. Mazariegos GV, Steffick DE, Horslen S, et al. Intestine transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 1020-1034.
20. Langnas AN, Shaw BW Jr, Antonson DL, et al. Preliminary experience with intestinal transplantation in infants and children. Pediatrics 1996; 97: 443-448.
21. Sudan DL, Iver KR, Deroover A, et al. A new technique for combined liver/small intestinal transplantation. Transplantation 2001; 72: 1846-1848.
22. Fishbein T, Florman S, Gondolesi G, Decker R., Noncomposite simultaneous liver and intestinal transplantation. Transplantation 2003; 75: 564-565.
23. Grant D, Abu-Elmagd K, Reves J, et al. 2003 report of the intestine transplant registry: A new era has dawned. Ann Surg 2005; 241: 604-613.
24. Kato T, Ruiz P, Thompson J, et al. Intestinal and multivisceral transplantation. World J Surg 2002; 26: 226-237.
25. Kato T, Selvaggi G, Gaynor JJ, et al. Inclusion of donor colon and ileocecal valve in intestinal transplantation. Transplantation 2008; 86: 293-297.
26. Matsumoto CA, Kaufman SS, Fishbein TM., Inclusion of the colon in intestinal transplantation. Curr Opin Organ Transplant 2011; 16: 312-315.
27. Levi DM, Tzakis AG, Kato T, et al. Transplantation of the abdominal wall. Lancet 2003; 361: 2173-2176.
28. Cipriani R, Contedini F, Santoli M, et al. Abdominal wall transplantation with microsurgical technique. Am J Transplant 2007; 7: 1304-1307.
29. Sheth J, Sharif K, Lloyd C, et al. Staged abdominal closure after small bowel or multivisceral transplantation. Pediatr Transplant 2012; 16: 36-40.
30. Mangus RS, Kubal CA, Tector AJ, Fridell JA, Klingler K, Vianna RM., Closure of the abdominal wall with acellular allograft in intestinal transplantation. Am J Transplant 2012; 12 (Suppl 4): S55-S59.
31. Ravindra KV, Martin AE, Vikraman DS, et al. Use of vascularized posterior rectus sheath allograft in pediatric multivisceral transplantation-Report of two cases. Am J Transplant 2012; 12: 2242-2246.
32. Gondolesi G, Selvaggi G, Tzakis A, et al. Use of the abdominal rectus fascia as a nonvascularized allograft for abdominal wall closure after liver, intestinal and multivisceral transplantation. Transplantation 2009; 87: 1884-1888.
33. Kato T, Mittal N, Nishida S, et al. The role of intestinal transplantation in the management of babies with extensive gut resections. J Pediatr Surg 2003; 38: 145-149.
34. Fishbein TM, Kaufman SS, Florman SS, et al. Isolated intestinal transplantation: Proof of clinical efficacy. Transplantation 2003; 76: 636-640.
35. Sudan DL, Kaufman SS, Shaw BW Jr, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenerol 2000; 95: 1506-1515.
36. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: Major advances with new challenges. Ann Surg 2009; 250: 567-581.
37. Farmer DG, Venick RS, Colangelo J, et al. Pretransplant predictors of survival after intestinal transplantation: Analysis of a single-center experience of more than 100 transplants. Transplantation 2010; 90: 1574-1580.
38. Lauro A, Bagni C, Zanfi S, et al. Mortality after steroid-resistant acute cellular rejection and chronic rejection episodes in adult intestinal transplants: Report from a single center in induction/preconditioning era. Transplant Proc 2013; 45: 2032-2033.
39. Abu-Elmaqd KM, Wu G, Costa G, et al. Preformed and de novo donor specific antibodies in visceral transplantation: Long-term outcome with special reference to the liver. Am J Transplant 2012; 12: 3047-3060.
40. Gerlach UA, Lachmann N, Sawitzki B, et al. Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation. Transpl Int 2014; 27: 280-289.
41. Kubal CA, Mangus RS, Vianna RM, et al. Impact of positive flow cytometry crossmatch on outcomes of intestinal/multivisceral transplantation: Role anti-IL-2 receptor antibody. Transplantation 2013; 95: 1160-1166.
42. Gerlach UA, Schoenemann C, Lachmann N, Koch M, Pascher A., Salvage therapy for refractory rejection and persistence of donor-specific antibodies after intestinal transplantation using the proteasome inhibitor bortezomib. Transpl Int 2011; 24: e43-e45.
43. De Greef E, Avitzur Y, Grant D, et al. Infliximab as salvage therapy in paediatric intestinal transplant with steroid-and thymoglobulin-resistant late acute rejection. J Pediatr Gastroenterol Nutr 2012; 54: 565-567.
44. Vianna RM, Mangus RS, Fridell JA, Weigman S, Kazimi M, Tector J., Inductions immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation 2008; 85: 1290-1293.
45. Gerlach UA, Koch M, Muller HP, Veltzke-Schlieker W, Neuhaus P, Pascher A., Tumor necrosis factor alpha inhibitors as immunomodulatory antirejection agents after intestinal transplantation. Am J Transplant 2011; 11: 1041-1050.
46. Island ER, Gonzalez-Pinto IM, Tsai HL, et al. Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. Clin Transpl 2009; 465-469.
47. Andersen DA, Horslen S., An analysis of the long-term complications of intestine transplant recipients. Prog Transplant 2004; 14: 277-282.
48. Florescu DF, Qui F, Langnas AN, et al. Bloodstream infections during the first year after pediatric small bowel transplantation. Pediatr Infect Dis J 2001; 31: 700-704.
49. Bueno J, Green M, Kocoshis S, et al. Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997; 25: 1078-1083.
50. Florescu DF, Langnas AN, Sandkovksy U., Opportunistic viral infections in intestinal transplantation. Expert Rev Anti Infect Ther 2014; 11: 367-381.
51. Ojo AO, Held PJ, Wolfe RA, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
52. Watson MJ, Venick RS, Kaldas F, et al. Renal function impacts outcomes after intestinal transplantation. Transplantation 2008; 86: 117-122.
53. Debray D, Baudouin V, Lacaille F, et al. De novo malignancy after solid organ transplantation in children. Transplant Proc 2009; 41: 674-675.
54. Abu-Elmagd KM, Mazariegos G, Costa G, et al. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: Improved outcomes with new outlooks. Transplantation 2009; 88: 926-934.
55. Lacaille F, Vass N, Sauvat F, et al. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation. Gut 2008; 57: 455-461.
56. Pironi L, Baxter JP, Lauro A, et al. Assessment of quality of life on home parenteral nutrition and after intestinal transplantation using treatment-specific questionnaires. Am J Transplant 2012; 12 (Suppl 4): S60-S66.
57. Abu-Elmagd KM, Kosmach-Park B, Costa G, et al. Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation. Ann Surg 2012; 256: 494-508.
58. Ngo KD, Farmer DG, McDiarmid SV, et al. Pediatric health-related quality of life after intestinal transplantation. Pediatr Transplant 2001; 15: 849-854.
59. Sudan D, Vargas L, Sun Y, et al. Calprotectin: A novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246: 311-315.
60. Akpinar E, Vargas J, Kato T, et al. Fecal calprotectin level measurements in small bowel allograft monitoring: A pilot study. Transplantation 2008; 85: 1281-1286.
61. Hibi T, Nishida S, Garcia J, et al. Citrulline level is a potent indicator of acute rejection in the long term following pediatric intestinal/multivisceral transplantation. Am J Transplant 2013; 12 (Suppl 4): S27-S32.
62. Ashokkhumar C, Gupta A, Sun Q, et al. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation. Surgery 2009; 146: 166-173.
63. Ashokkumar C, Talukdar A, Sun Q, et al. Allospecific CD154+ T cells associate with rejection after pediatric liver transplantation. Am J Transplant 2009; 9: 179-191.
64. Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004; 240: 748-754.
65. Sala FG, Kunisaki SM, Ochoa ER, et al. Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res 2009; 156: 205-212.
66. Fuller MK, Faulk DM, Sundaram N, et al. Intestinal crypts reproducibly expand in culture. J Surg Res 2102; 178: 48-54.
67. Patil PB, Chougule PB, Kumar VK, et al. Recellularization of acellular human small intestine using bone marrow stem cells. Stem Cells Transl Med 2013; 2: 307-315.
68. Maghsoudlou P, Totonelli G, Loukogeorgakis SP, Eaton S, De Coppi P., A decellularization methodology for the production of a natural acellular intestinal matrix. J Vis Exp 2013; e50658.